Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07536282 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of NWRD09 for Female Participants With Persistent HPV16 Infection

StatusNot Yet Recruiting
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This is a two-part, phase I/IIa study, intended to evaluate the safety, tolerability, immunogenicity, and efficacy of NWRD09 in female participants with persistent HPV16 infection, and to determine the MTD, and/or RP2D of NWRD09.
Trial Details
NCT Number NCT07536282
Lead Sponsor Newish Biotech (Wuxi) Co., Ltd.
Conditions
(from sponsor)		 Persistent HPV16 Infection
Enrollment 78 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov